A Study of the Efficacy of Botox in the Treatment of Social Anxiety Disorder

• Status: Terminated
• Trial end date: 2017-09-12
• Target enrollment: 0
• Participant gender: All

Summary

The goal of this study is to see whether Botox is an effective treatment for social anxiety disorder (SAD). Participants will complete two short surveys on depression and anxiety symptoms, receive a one-time injection of Botox, and complete the depression and anxiety survey 4 weeks after injection and again at 8 weeks after injection.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Daniel Lieberman; George Washington University
• Treatments: abobotulinumtoxinA; Botulinum Toxins; Botulinum Toxins, Type A; onabotulinumtoxinA

Criteria

Inclusion Criteria:

• primary diagnosis of social anxiety disorder

• women of childbearing potential on an acceptable form of birth control and are not pregnant or lactating

Exclusion Criteria:

• has ever been treated with botulinum toxin A

• has another Axis I diagnosis within in the 6-months prior to screening

• history of substance abuse within 2-months of screening

• current or recent suicidality

• scoring greater than 2 on Beck Depression Inventory (BDI) suicidality question

• psychotic or bipolar disorder

• unstable medical condition

• changes in medication or psychotherapy treatment in the month prior to screening

• significant risk of committing homicide